
Sign up to save your podcasts
Or


Welcome to Reimbursement Pathways for Psychedelic Therapies, the podcast that investigates how psychedelics become reimbursed care.
I’m Floris Wolswijk, project manager at Delphi and founder of Blossom, and I'm on a journey to investigate how we can get psychedelics to become a part of mainstream healthcare.
Each month, I'll interview health economists, payers, drug developers, and policy architects who are shaping tomorrow's market access rules.
We'll investigate the clinical evidence, access pathways, and the healthcare systems that need to implement psychedelics.
If you research psychedelics, work in policy or reimbursement, or are just curious about this journey, then subscribe to this podcast on Spotify, Apple Podcasts, or wherever quality podcasts are found.
New episodes drop every second Wednesday.
Subscribe now and be in a room when reimbursement history is written.
By Floris WolswijkWelcome to Reimbursement Pathways for Psychedelic Therapies, the podcast that investigates how psychedelics become reimbursed care.
I’m Floris Wolswijk, project manager at Delphi and founder of Blossom, and I'm on a journey to investigate how we can get psychedelics to become a part of mainstream healthcare.
Each month, I'll interview health economists, payers, drug developers, and policy architects who are shaping tomorrow's market access rules.
We'll investigate the clinical evidence, access pathways, and the healthcare systems that need to implement psychedelics.
If you research psychedelics, work in policy or reimbursement, or are just curious about this journey, then subscribe to this podcast on Spotify, Apple Podcasts, or wherever quality podcasts are found.
New episodes drop every second Wednesday.
Subscribe now and be in a room when reimbursement history is written.